134 related articles for article (PubMed ID: 32961011)
21. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
22. Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia.
Habib LK; Finn WG
Cytometry B Clin Cytom; 2006 May; 70(3):124-35. PubMed ID: 16498670
[TBL] [Abstract][Full Text] [Related]
23. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis.
te Raa GD; Fischer K; Verweij W; van Houte AJ; Kater AP; Biesma DH
Clin Chem Lab Med; 2011 Jan; 49(1):115-20. PubMed ID: 21054188
[TBL] [Abstract][Full Text] [Related]
24. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
[TBL] [Abstract][Full Text] [Related]
25. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
[No Abstract] [Full Text] [Related]
26. Novel lymphocyte screening tube using dried monoclonal antibody reagents.
Hedley BD; Keeney M; Popma J; Chin-Yee I
Cytometry B Clin Cytom; 2015; 88(6):361-70. PubMed ID: 25944189
[TBL] [Abstract][Full Text] [Related]
27. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
29. [The interpretation of immunophenotyping results during diagnostics of lymphatic proliferative disease using immunophenotyping count].
Isaeva NV; Zaĭtseva GA; Zagoskina TP
Klin Lab Diagn; 2013 Feb; (2):30-3. PubMed ID: 23808007
[TBL] [Abstract][Full Text] [Related]
30. CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.
Schmieg JJ; Muir JM; Aguilera NS; Auerbach A
Curr Oncol; 2021 Dec; 28(6):5124-5147. PubMed ID: 34940069
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital.
Gujral S; Polampalli SN; Badrinath Y; Kumar A; Subramanian PG; Nair R; Gupta S; Sengar M; Nair C
Leuk Lymphoma; 2009 Aug; 50(8):1290-300. PubMed ID: 19811331
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis of chronic B-cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data.
Gross Z; Veyrat-Masson R; Grange B; Huet S; Verney A; Traverse-Glehen A; Ruminy P; Baseggio L
Hematol Oncol; 2024 Jan; 42(1):e3245. PubMed ID: 38287532
[TBL] [Abstract][Full Text] [Related]
34. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
35. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
[TBL] [Abstract][Full Text] [Related]
36. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
37. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
38. Expression of CD43 in chronic lymphoproliferative leukemias.
Sorigue M; Juncà J; Sarrate E; Grau J
Cytometry B Clin Cytom; 2018 Jan; 94(1):136-142. PubMed ID: 28073173
[TBL] [Abstract][Full Text] [Related]
39. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
40. Optimization and Validation of an 8-Color Single-Tube Assay for the Sensitive Detection of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia Detected via Flow Cytometry.
Dowling AK; Liptrot SD; O'Brien D; Vandenberghe E
Lab Med; 2016 May; 47(2):103-11. PubMed ID: 27069028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
